• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成用于研究代谢应激诱导的肝纤维化的人源肝球体的方案。

Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress.

机构信息

Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA 92093, USA.

Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA 92093, USA; Department of Surgery, University of California, San Diego, School of Medicine, La Jolla, CA 92093, USA.

出版信息

STAR Protoc. 2024 Jun 21;5(2):103111. doi: 10.1016/j.xpro.2024.103111. Epub 2024 Jun 3.

DOI:10.1016/j.xpro.2024.103111
PMID:38833372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11179098/
Abstract

Currently, there is no effective treatment for obesity and alcohol-associated liver diseases, partially due to the lack of translational human models. Here, we present a protocol to generate 3D human liver spheroids that contain all the liver cell types and mimic "livers in a dish." We describe strategies to induce metabolic and alcohol-associated hepatic steatosis, inflammation, and fibrosis. We outline potential applications, including using human liver spheroids for experimental and translational research and drug screening to identify potential anti-fibrotic therapies.

摘要

目前,肥胖和酒精性肝病尚无有效的治疗方法,部分原因是缺乏转化型人类模型。在此,我们提出了一种生成包含所有肝细胞类型并模拟“盘中之肝”的 3D 人类肝球体的方案。我们描述了诱导代谢和酒精相关性肝脂肪变性、炎症和纤维化的策略。我们概述了潜在的应用,包括使用人类肝球体进行实验和转化研究以及药物筛选,以确定潜在的抗纤维化治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/616a251c2fc0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/0e03bd478a6a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/785666f755be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/9ecd0bbaa1d6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/0a64b5f06430/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/ec20fa3e457e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/616a251c2fc0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/0e03bd478a6a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/785666f755be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/9ecd0bbaa1d6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/0a64b5f06430/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/ec20fa3e457e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d5/11179098/616a251c2fc0/gr5.jpg

相似文献

1
Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress.生成用于研究代谢应激诱导的肝纤维化的人源肝球体的方案。
STAR Protoc. 2024 Jun 21;5(2):103111. doi: 10.1016/j.xpro.2024.103111. Epub 2024 Jun 3.
2
Human iPSC-derived liver co-culture spheroids to model liver fibrosis.用于模拟肝纤维化的人诱导多能干细胞衍生的肝脏共培养球体。
Biofabrication. 2024 Jun 28;16(3). doi: 10.1088/1758-5090/ad5766.
3
Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis.人多谱系 3D 球体作为肝脂肪变性和纤维化的模型。
Int J Mol Sci. 2019 Apr 2;20(7):1629. doi: 10.3390/ijms20071629.
4
Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.索拉非尼可减少非酒精性脂肪性肝病的人源 3D 共培养模型中脂肪变性诱导的肝纤维化。
Environ Toxicol. 2021 Feb;36(2):168-176. doi: 10.1002/tox.23021. Epub 2020 Sep 12.
5
Human hepatic 3D spheroids as a model for steatosis and insulin resistance.人源肝 3D 球体作为脂肪变性和胰岛素抵抗的模型。
Sci Rep. 2018 Sep 24;8(1):14297. doi: 10.1038/s41598-018-32722-6.
6
Self-Healing Hydrogel Containing Decellularized Liver Matrix and Endothelial Cell-Covered Hepatocyte Spheroids for Rescue of Injured Hepatocytes.载有去细胞化肝基质和被内皮细胞覆盖的肝细胞球体的自修复水凝胶,用于修复受损的肝细胞。
Macromol Biosci. 2024 May;24(5):e2300411. doi: 10.1002/mabi.202300411. Epub 2024 Feb 13.
7
Modelling fatty liver disease with mouse liver-derived multicellular spheroids.利用小鼠肝源多细胞球体模拟脂肪肝疾病。
Biomaterials. 2022 Nov;290:121817. doi: 10.1016/j.biomaterials.2022.121817. Epub 2022 Sep 28.
8
The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation.原代肝球体的纤维化反应重现了体内肝星状细胞的激活。
Biomaterials. 2020 Dec;261:120335. doi: 10.1016/j.biomaterials.2020.120335. Epub 2020 Aug 22.
9
Multi-cellular transitional organotypic models to investigate liver fibrosis.用于研究肝纤维化的多细胞过渡型器官型模型。
Acta Biomater. 2018 Dec;82:79-92. doi: 10.1016/j.actbio.2018.10.010. Epub 2018 Oct 11.
10
An in vitro 3D spheroid model with liver steatosis and fibrosis on microwell arrays for drug efficacy evaluation.一种用于药物疗效评估的、在微孔阵列上具有肝脂肪变性和纤维化的体外3D球体模型。
J Biotechnol. 2025 Mar;399:153-163. doi: 10.1016/j.jbiotec.2025.01.019. Epub 2025 Jan 29.

引用本文的文献

1
DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids.DHCR7抑制可改善小鼠和人3D肝球体中的代谢性脂肪性肝病和肝癌。
JHEP Rep. 2025 Apr 5;7(7):101415. doi: 10.1016/j.jhepr.2025.101415. eCollection 2025 Jul.
2
Recent Advances in Three-Dimensional In Vitro Models for Studies of Liver Fibrosis.用于肝纤维化研究的三维体外模型的最新进展
Tissue Eng Regen Med. 2025 May 13. doi: 10.1007/s13770-025-00719-8.
3
Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine.
解读肝纤维化:组学技术与创新模型如何引领精准医学
Int J Mol Sci. 2025 Mar 15;26(6):2658. doi: 10.3390/ijms26062658.
4
-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing Steatohepatitis.-半胱胺:一种氘代半胱胺衍生物,在纤维化性脂肪性肝炎小鼠模型中具有增强的抗炎和抗纤维化活性。
ACS Pharmacol Transl Sci. 2025 Feb 24;8(3):885-898. doi: 10.1021/acsptsci.4c00738. eCollection 2025 Mar 14.
5
Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease.人肝星状细胞的多模态分析确定了代谢功能障碍相关脂肪性肝病的新治疗靶点。
J Hepatol. 2025 May;82(5):882-897. doi: 10.1016/j.jhep.2024.10.044. Epub 2024 Nov 8.
6
Modelling human liver disease: from steatotic liver disease to MASH-HCC.人类肝脏疾病建模:从脂肪性肝病到MASH-HCC
Nat Rev Endocrinol. 2025 Jan;21(1):10-11. doi: 10.1038/s41574-024-01054-z.